The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pulmonary veno-occlusive disease
Publications
Ranchoux B, Günther S, Quarck R, Chaumais MC, Dorfmüller P, Antigny F, Dumas SJ, Raymond N, Lau E, Savale L, Jaïs X, Sitbon O, Simonneau G, Stenmark K, Cohen-Kaminsky S, Humbert M, Montani D, Perros F
Chemotherapy-induced pulmonary hypertension: role of alkylating agents.
The American journal of pathology 2015 Feb;185;356-71 — 2015 Feb — 356-71
Pulmonary veno-occlusive disease: an 80-year-old mystery.
Respiration; international review of thoracic diseases 2014;88;148-57 — 2014 — 148-57
Miyata D, Fukushima T, Matsunaga M, Saito N, Kato Y, Takahashi-Igari M, Horigome H, Sumazaki R, Yamaki S, Matsui A
Fatal pulmonary veno-occlusive disease after chemotherapy for Burkitt's lymphoma.
Pediatrics international : official journal of the Japan Pediatric Society 2011 Jun;53;403-5 — 2011 Jun — 403-5
Pulmonary veno-occlusive disease after chemotherapy.
Human pathology 1983 Jan;14;88-91 — 1983 Jan — 88-91